Clinical trial
Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients…
NCT00369928 · Procter and Gamble, Industry · Completed
Key facts
| NCT number | NCT00369928 |
|---|---|
| Title | Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate |
| Official title | A Multicenter, Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of 2 Oral Doses, 25 mg Twice Daily and 100 mg Twice Daily, of PG-760564 in Adult Patients With RA Receiving Methotrexate |
| Lead sponsor | Procter and Gamble, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | PG-760564, Placebo dose |
| Enrollment | 254 |
| Start date | Aug 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Aug 30, 2006 |
| Last update posted | Sep 8, 2011 |
| Countries | Czechia, Hungary, Netherlands, Poland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: